Clinical Trial Update: Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial of a gene therapy for cardiomyopathy associated with Friedreich's ataxia is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiomyopathy
• Friedreich Ataxia

Snippet

Sponsor: Lexeo Therapeutics | Conditions: Friedreich Ataxia, Cardiomyopathy, Secondary | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING